Bausch Health Companies I... (BHC)
Bausch Health Companies Statistics
Share Statistics
Bausch Health Companies has 369.51M shares outstanding. The number of shares has increased by 0.31% in one year.
Shares Outstanding | 369.51M |
Shares Change (YoY) | 0.31% |
Shares Change (QoQ) | 0.04% |
Owned by Institutions (%) | 68.73% |
Shares Floating | 291.56M |
Failed to Deliver (FTD) Shares | 1.14K |
FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 7.85M, so 2.13% of the outstanding shares have been sold short.
Short Interest | 7.85M |
Short % of Shares Out | 2.13% |
Short % of Float | 2.31% |
Short Ratio (days to cover) | 4.4 |
Valuation Ratios
The PE ratio is -64.48 and the forward PE ratio is 1.1. Bausch Health Companies's PEG ratio is 0.7.
PE Ratio | -64.48 |
Forward PE | 1.1 |
PS Ratio | 0.31 |
Forward PS | 0.2 |
PB Ratio | -2.32 |
P/FCF Ratio | 2.35 |
PEG Ratio | 0.7 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Bausch Health Companies.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.86, with a Debt / Equity ratio of -2.09.
Current Ratio | 0.86 |
Quick Ratio | 0.62 |
Debt / Equity | -2.09 |
Debt / EBITDA | 1.73 |
Debt / FCF | 2.12 |
Interest Coverage | 1.11 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $459.81K |
Profits Per Employee | $-2.22K |
Employee Count | 20,700 |
Asset Turnover | 0.36 |
Inventory Turnover | 1.74 |
Taxes
Income Tax | 239M |
Effective Tax Rate | 143.11% |
Stock Price Statistics
The stock price has increased by -40.35% in the last 52 weeks. The beta is 0.43, so Bausch Health Companies's price volatility has been higher than the market average.
Beta | 0.43 |
52-Week Price Change | -40.35% |
50-Day Moving Average | 6.43 |
200-Day Moving Average | 7.2 |
Relative Strength Index (RSI) | 39.07 |
Average Volume (20 Days) | 2.89M |
Income Statement
In the last 12 months, Bausch Health Companies had revenue of 9.52B and earned -46M in profits. Earnings per share was -0.13.
Revenue | 9.52B |
Gross Profit | 6.74B |
Operating Income | 1.55B |
Net Income | -46M |
EBITDA | 1.55B |
EBIT | 1.55B |
Earnings Per Share (EPS) | -0.13 |
Balance Sheet
The company has 1.18B in cash and 2.67B in debt, giving a net cash position of -1.49B.
Cash & Cash Equivalents | 1.18B |
Total Debt | 2.67B |
Net Cash | -1.49B |
Retained Earnings | -9.82B |
Total Assets | 26.52B |
Working Capital | -978M |
Cash Flow
In the last 12 months, operating cash flow was 1.6B and capital expenditures -337M, giving a free cash flow of 1.26B.
Operating Cash Flow | 1.6B |
Capital Expenditures | -337M |
Free Cash Flow | 1.26B |
FCF Per Share | 3.42 |
Margins
Gross margin is 70.77%, with operating and profit margins of 16.24% and -0.48%.
Gross Margin | 70.77% |
Operating Margin | 16.24% |
Pretax Margin | 1.75% |
Profit Margin | -0.48% |
EBITDA Margin | 16.24% |
EBIT Margin | 16.24% |
FCF Margin | 13.24% |
Dividends & Yields
BHC pays an annual dividend of $1.37, which amounts to a dividend yield of 4.99%.
Dividend Per Share | $1.37 |
Dividend Yield | 4.99% |
Dividend Growth (YoY) | -76% |
Payout Ratio | -1053.85% |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for BHC is $8, which is 55.9% higher than the current price. The consensus rating is "Hold".
Price Target | $8 |
Price Target Difference | 55.9% |
Analyst Consensus | Hold |
Analyst Count | 5 |
Stock Splits
The last stock split was on Oct 16, 2000. It was a forward split with a ratio of 2:1.
Last Split Date | Oct 16, 2000 |
Split Type | forward |
Split Ratio | 2:1 |
Scores
Altman Z-Score | 0.03 |
Piotroski F-Score | 4 |